How Much Will the UAW Strike Really Cost GM?
The true cost to General Motors of the ongoing UAW strike will grow exponentially the longer it drags on.
Walmart's Going After Another Pillar of Amazon's Business
Fulfillment by Amazon has been huge for the e-commerce giant. Can Walmart replicate its success?
Why Southwest Airlines Is Shrugging Off the Oil Price Spike (but American Airlines Isn't)
Southwest Airlines' high profit margin and its fuel hedges should help it withstand the recent jump in oil prices.
After 20 years of leading the upscale purveyor of beauty products and spa treatments, co-founders Marla Malcolm Beck and Barry Beck are ready to move on.
Despite a booming sector, it had bigger dreams as a pharmacy giant.
Two of the three leading premium music platforms may have more than 30 million premium North American members apiece, but they aren't playing the same tune.
A wearable tech pioneer, enterprise data cloud specialist, and hardwood flooring retailer may have fallen into the single digits, but they can get up again.
Management's No. 1 priority is engineering a return to sales growth.
You might be surprised at the winner of this showdown.
Studies on cannabidiol and what it can and cannot do have been limited, but that hasn't stopped advertisers from making some very aggressive claims.
If you're one of them, consider this an important wake-up call.
Find out why these new healthcare stocks keep climbing, while most of their peers have underwhelmed.
These two palladium producers are witnessing impressive growth right now.
These companies are all trading for extremely low earnings multiples and could be excellent long-term bargains.
If you're a skill-heavy employee, that's good news, according to a report from LinkedIn.
Are these pot stocks bargains or value traps?
Most are hard to get and require a lot of training.
The stock is coming off a new low and could be a steal of a deal given how much growth it could achieve.
Cannabis stocks have been awful since the end of March, and that trend may continue for a while.
These stocks are an income investor's dream come true.
The second attempt at spinning off the international division could still allow the company to come out ahead in the end.
Amgen's recent clinical setback just might prompt the big biotech to light a fire beneath its acquisition efforts.
These 2 Cannabis Companies Kicked In Over $1 Million to Legalize Pot in Florida. Will Their Bets Pay Off?
Sunny beaches, popular theme parks -- and recreational marijuana? Big bucks are flowing in to make legal pot in Florida a reality.